These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28108630)

  • 21. Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma.
    Neuzillet C; Babai S; Kempf E; Pujol G; Rousseau B; Le-Louët H; Christophe Tournigand
    Medicine (Baltimore); 2016 Jun; 95(26):e4006. PubMed ID: 27368013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma.
    Wagner LM; Yin H; Eaves D; Currier M; Cripe TP
    Pediatr Blood Cancer; 2014 Nov; 61(11):2096-8. PubMed ID: 24753077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines.
    Braun LM; Lagies S; Guenzle J; Fichtner-Feigl S; Wittel UA; Kammerer B
    Cells; 2020 May; 9(5):. PubMed ID: 32438599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment.
    Chen CJ; Wang HC; Hou YC; Wu YY; Shieh CC; Shan YS
    Mol Cancer Ther; 2024 Oct; 23(10):1431-1445. PubMed ID: 38907533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nab-paclitaxel].
    Lopez-Trabada Ataz D; Dumont S; André T
    Bull Cancer; 2015 Jun; 102(6):568-76. PubMed ID: 26008630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW; Hidalgo M
    Clin Cancer Res; 2013 Oct; 19(20):5572-9. PubMed ID: 23918602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nab-paclitaxel: a flattering facelift.
    Viúdez A; Ramírez N; Hernández-García I; Carvalho FL; Vera R; Hidalgo M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):166-80. PubMed ID: 25048167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes.
    Kolyvas E; Rudloff M; Poruchynsky M; Landsman R; Hollevoet K; Venzon D; Alewine C
    Oncotarget; 2017 Feb; 8(6):9189-9199. PubMed ID: 27999204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.
    Zhu M; Zhang P; Yu S; Tang C; Wang Y; Shen Z; Chen W; Liu T; Cui Y
    J Exp Clin Cancer Res; 2022 Jan; 41(1):14. PubMed ID: 34996504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy evaluation of albumin-bound paclitaxel.
    Cecco S; Aliberti M; Baldo P; Giacomin E; Leone R
    Expert Opin Drug Saf; 2014 Apr; 13(4):511-20. PubMed ID: 24559090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
    Hosein PJ; de Lima Lopes G; Pastorini VH; Gomez C; Macintyre J; Zayas G; Reis I; Montero AJ; Merchan JR; Rocha Lima CM
    Am J Clin Oncol; 2013 Apr; 36(2):151-6. PubMed ID: 22307213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
    Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
    Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP).
    Houghton PJ; Kurmasheva RT; Kolb EA; Gorlick R; Maris JM; Wu J; Tong Z; Arnold MA; Chatterjee M; Williams TM; Smith MA
    Pediatr Blood Cancer; 2015 Jul; 62(7):1214-21. PubMed ID: 25809532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    Bioengineered; 2022 Jan; 13(1):1942-1951. PubMed ID: 35019820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal expression of SPARC in pancreatic adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Cros J; Faivre S; Hammel P; Raymond E
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):585-602. PubMed ID: 23690170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Wiedenmann N; Valdecanas D; Hunter N; Hyde S; Buchholz TA; Milas L; Mason KA
    Clin Cancer Res; 2007 Mar; 13(6):1868-74. PubMed ID: 17363543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer.
    Vishnu P; Roy V
    Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.
    Demeure MJ; Stephan E; Sinari S; Mount D; Gately S; Gonzales P; Hostetter G; Komorowski R; Kiefer J; Grant CS; Han H; Von Hoff DD; Bussey KJ
    Ann Surg; 2012 Jan; 255(1):140-6. PubMed ID: 22156929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.